Wells Fargo Maintains Overweight on Tenet Healthcare, Lowers Price Target to $229

Benzinga · 5d ago
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $252 to $229.